Nanocrine

Curated by Signal

Provider of a cell analysis and drug design tool for researchers

Overview

Provider of cell analysis and drug design tool for researchers. The company is developing cell imaging solutions for researchers to monitor cells by using a nano-biosensor technology platform that uses existing light microscopic workflows with integrated software and A.I. tools.

Key facts

Founded: 2018
Headquarters: Frederick, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Odyssey Health
Developer of therapies and devices for acute brain, cardiovascular and respiratory diseases
Life Sciences TechnologyLas Vegas, United States
DNA Software
Developer of a software for primer and probe design
Life Sciences TechnologyAnn Arbor, United States
Cerebrotech Medical
Non-invasive & continuous monitoring for early detection of cerebral bleeding & edema
Life Sciences TechnologyPleasanton, United States

About Nanocrine

What does Nanocrine do?

Provider of cell analysis and drug design tool for researchers.

Where is Nanocrine headquartered?

Nanocrine is headquartered in Frederick, United States.

When was Nanocrine founded?

Nanocrine was founded in 2018.

Which sector is Nanocrine in?

Nanocrine operates in Life Sciences Technology.

Who are Nanocrine's competitors?

Companies similar to Nanocrine include Odyssey Health, DNA Software, and Cerebrotech Medical.